Ireland
--:--IST
Latest
Clinical Trials in France / NCT06477900
Recruiting Not applicable

Impact of SMS Reminder on Weight Loss, as Part of a Health Pathway in Patients With Prediabetes (PREDIABCOACH)

NCT06477900 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-01-22
Last updated
2026-03-19

Condition(s) studied

PreDiabetes

Investigational drug(s) / intervention(s)

SMS reception

SMS reception: reception of 72 SMS encouraging physical activity and nutritional advice

Study summary

The goal of this interventionnal study is to demonstrate that sending SMS messages with advice on physical activity or nutrition, in addition to a program of hygienic-dietary management, significantly increases weight loss in subjects with prediabetes in La Réunion.

Indeed, type 2 diabetes is a priority health problem on Reunion Island: 10% of the population are treated for type 2 diabetes, twice as many as in France.

International studies have demonstrated the value of modifying dietary and physical activity habits to reduce the risk of transition to diabetes in patients with prediabetes Against this backdrop, a Regional Nutrition Diabetes Program (PRND) 2020-2023 was launched by Réunion's Regional Health Agency (ARS) in 2020.

Studies have also demonstrated the effectiveness of using SMS to encourage and support weight loss interventions.

So, the main question it aims to answer are:

• Does the addition of 72 SMS of physical activity and nutriton advice, to the "FindRisc Péi-CPTS" program, significantly increase weight loss by 3% after 6 months of starting the program.

FindRiscPei-CPTS program includes sports sessions, dietary consultations and therapeutic education.

The 300 participants will be randomized into two arms

* 150 participants will take part in the FindRiscPei-CPTS program + receive SMS messages
* 150 participants will only take part in the FindRiscPei-CPTS program (no SMS)

All participants will follow procedures below:

* Inclusion: assessment of weight and waist circumference, Lifestyle Questionnaire and Socio-Efficacy Questionnaire.
* Participation in Findrisk program for 3 to 9 months (+ SMS for experimental group)
* 3 follow-up visits: 3 months, 6 months and 9 months after starting the program: weight and waist measurement, self-efficacy questionnaire.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Subject with prediabetes as defined by HAS (fasting blood glucose \> 1.10g/L and \< 1.26g/L; or blood glucose 2h after ingestion of 10g of glucose \> 1.40g/L and \< 2g/L \[HGPO test\]) * included in a health and diet care program for patients with pre-diabetes offered by one of Réunion's CPTS (FindRisc Péi-CPTS program) * age \> 18 years * in possession of an SMS-enabled telephone * able to complete self-efficacy questionnaires * not expected to move within 12 months Exclusion Criteria: * participant currently being monitored in the PREDIABRUN study * protected adults (under guardianship or curatorship) * pregnant women * refusal to participate in the study * patients unable to speak Creole or French

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Communauté Professionnelle Territoriale de Santé (CPTS RéSO) Saint-Louis Réunion Recruiting
Territorial Health Professional Community (CPTS) Grand Sud Saint-Philippe Reunion Not Yet Recruiting

More Centre Hospitalier Universitaire de la Réunion trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06477900 on ClinicalTrials.gov ↗ ← All trials in France